Blackstone Life Sciences clinches royalty deal with Medtronic, Apollo-spinout Nexus Capital targets $1bn-plus for next fund, Kinderhook's Avita sees big opportunity in pharmacy management
Blackstone invests in Medtronic and Nexus Capital targets $1 billion for new fund.
15 June 2020•3 mins read
